Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panhematin in Acute Attacks of Porphyria
NCT02180412Phase 2Completed
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Apr 2014
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hemin in acute porphyria, sponsored by The University of Texas Medical Branch at Galveston. Started Apr 2014; status: completed.
02
Drugs
hemin
03
Conditions
acute porphyria
Beyond the preview
Go deeper on NCT02180412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02180412.